UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
Scholastic
SCHL
$807M
| $1.38M | ﹤0.01% |
35,000
-1,626
| -4% | -$60.4K |
|
1652
Brinker International
EAT
$9.76B
| $1.38M | ﹤0.01% |
43,192
+940
| +2% | +$29.6K |
|
1653
Ingles Markets
IMKTA
$1.62B
| $1.37M | ﹤0.01% |
14,245
| – | – |
|
1654
Expro Ltd
XPRO
$2.01B
| $1.37M | ﹤0.01% |
75,296
+12,454
| +20% | +$211K |
|
1655
Twist Bioscience
TWST
$7.83B
| $1.35M | ﹤0.01% |
56,895
+2,601
| +5% | +$75.4K |
|
1656
Worthington Enterprises
WOR
$2.79B
| $1.35M | ﹤0.01% |
44,183
-23,792
| -35% | -$737K |
|
1657
Embecta
EMBC
$296M
| $1.35M | ﹤0.01% |
53,355
-1,504
| -3% | -$45.9K |
|
1658
Celldex Therapeutics
CLDX
$3.37B
| $1.35M | ﹤0.01% |
30,242
| – | – |
|
1659
SiTime
SITM
$20.7B
| $1.34M | ﹤0.01% |
13,220
+1,023
| +8% | +$96.7K |
|
1660
Appian
APPN
$2.55B
| $1.34M | ﹤0.01% |
41,084
-1,197
| -3% | -$47.2K |
|
1661
Travere Therapeutics
TVTX
$5.74B
| $1.34M | ﹤0.01% |
63,578
+1,152
| +2% | +$24.4K |
|
1662
Seaboard Corp
SEB
$4.06B
| $1.34M | ﹤0.01% |
354
-3
| -0.8% | -$11.3K |
|
|
RNAM
1663
DELISTED
Avidity Biosciences
RNAM
| $1.34M | ﹤0.01% |
60,177
+36,455
| +154% | +$544K |
|
1664
Asana
ASAN
$2.13B
| $1.33M | ﹤0.01% |
96,628
+29,307
| +44% | +$532K |
|
1665
Laureate Education
LAUR
$5.13B
| $1.33M | ﹤0.01% |
138,143
-10,701
| -7% | -$116K |
|
1666
Oxford Industries
OXM
$556M
| $1.33M | ﹤0.01% |
14,222
-1,620
| -10% | -$162K |
|
1667
Telephone and Data Systems
TDS
$3.84B
| $1.32M | ﹤0.01% |
125,886
+22,039
| +21% | +$273K |
|
|
NXGN
1668
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.32M | ﹤0.01% |
70,210
+635
| +0.9% | +$12.2K |
|
|
CSW
1669
CSW Industrials
CSW
$5.67B
| $1.32M | ﹤0.01% |
11,360
| – | – |
|
1670
ePlus
PLUS
$2.35B
| $1.31M | ﹤0.01% |
29,569
| – | – |
|
1671
Virtus Investment Partners
VRTS
$1.11B
| $1.3M | ﹤0.01% |
6,797
+505
| +8% | +$90.3K |
|
1672
Westamerica Bancorp
WABC
$1.35B
| $1.3M | ﹤0.01% |
22,034
| – | – |
|
1673
Clearfield
CLFD
$391M
| $1.3M | ﹤0.01% |
13,811
+770
| +6% | +$81.2K |
|
1674
Stock Yards Bancorp
SYBT
$2.58B
| $1.29M | ﹤0.01% |
19,896
+393
| +2% | +$28.1K |
|
1675
TriMas Corp
TRS
$1.43B
| $1.29M | ﹤0.01% |
46,564
-2,352
| -5% | -$62.8K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.